Cost–Utility Analysis of Dapagliflozin as an Add-on to Standard of Care for Patients with Chronic Kidney Disease in Thailand

by Kriengsak Vareesangthip, Chaicharn Deerochanawong, Dittaya Thongsuk, Nuch Pojchaijongdee, Unchalee Permsuwan
Published 2022

Resource utilization and direct medical costs of chronic hepatitis C in Thailand: A heavy but manageable economic burden

by Satawat Thongsawat, Teerha Piratvisuth, Chutima Pramoolsinsap, Anuchit Chutaputti, Tawesak Tanwandee, Dittaya Thongsuk
Published 2018

Resource utilization and direct medical costs of chronic hepatitis C in Thailand: A heavy but manageable economic burden

by Satawat Thongsawat, Teerha Piratvisuth, Chutima Pramoolsinsap, Anuchit Chutaputti, Tawesak Tanwandee, Dittaya Thongsuk
Published 2018

Resource utilization and direct medical costs of chronic hepatitis C in Thailand: A heavy but manageable economic burden

by Satawat Thongsawat, Teerha Piratvisuth, Chutima Pramoolsinsap, Anuchit Chutaputti, Tawesak Tanwandee, Dittaya Thongsuk
Published 2018

Cost–Utility Analysis of Dapagliflozin as an Add-On to Standard Treatment for Patients with Type 2 Diabetes and High Risk of Cardiovascular Disease in Thailand

by Chaicharn Deerochanawong, Kriengsak Vareesangthip, Dilok Piyayotai, Dittaya Thongsuk, Nuch Pojchaijongdee, Unchalee Permsuwan
Published 2022